Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03285880 · ClinicalTrials.gov registry record · NA
The Benefits of Naps on Cognitive, Emotional, and Motor Learning in Preschoolers
A NA study, sponsored by University of Massachusetts, Amherst.
- Terminated
- Registry status
- NA
- Development phase
- 361
- Enrollment target
NCT03285880: Clinical Trial NA study, sponsored by University of Massachusetts, Amherst.
NCT03285880 is a NA study that was terminated before completion, run by University of Massachusetts, Amherst. The registered enrollment target is 361 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03285880, a NA study, was terminated before completion, sponsored by University of Massachusetts, Amherst.
- TERMINATED
- Registry status
- NA
- Development phase
- 361 participants
- Enrollment target
Study Summary
The specific objective of the proposed research is to examine whether naps contribute to immediate and delayed benefits on multiple forms of learning in young children (3-5 yrs). By probing recall prior to and following mid-day nap or wake intervals, the overarching hypothesis is that recent memories are actively processed (as opposed to passively protected) by a nap, conferring immediate or delayed (24-hrs) benefits on declarative (Aim 1), procedural (Aim 2), and emotional (Aim 3) memories. In two conditions, children will either be nap-promoted or wake-promoted midday. Subsequently, performance will be reassessed that day as well as the following day.
Primary Outcome
Accuracy on the memory task following the nap compared to before the nap relative to the same memory change measured over an interval spent awake
Interventions
- BEHAVIORAL Napping
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 361 participants |
| Start Date | 2017-09-01 |
| Est. Completion | 2022-06-30 |
| Phase | NA |
Why NCT03285880 stopped before completion
NCT03285880 is an interventional study that assigns participants to a tested intervention. The registered 361 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 1 intervention - of which Napping is the first listed.
NCT03285880 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03285880 about?
NCT03285880 is a clinical study titled "The Benefits of Naps on Cognitive, Emotional, and Motor Learning in Preschoolers". The specific objective of the proposed research is to examine whether naps contribute to immediate and delayed benefits on multiple forms of learning in young children (3-5 yrs). By probing recall prior to and following mid-day nap or wake intervals, the overarching hypothesis is that recent memorie...
What is the current status of trial NCT03285880?
This trial is currently terminated. It is a NA study. The enrollment target is 361 participants. The study started on 2017-09-01. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT03285880?
The interventions under investigation include: Napping (BEHAVIORAL).
Who is sponsoring clinical trial NCT03285880?
This trial is sponsored by University of Massachusetts, Amherst, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03285880's enrollment target sits among peer trials
361 284th of 2000 higher than 1,717 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05533697 · 361 participants · Phase 1
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
- NCT04988555 · 362 participants · Phase 1
A Study of DSP-5336 in Relapsed/Refractory AML/ ALL With or Without MLL Rearrangement or NPM1 Mutation
- NCT05536141 · 362 participants · Phase 1
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
- NCT06534983 · 362 participants · Phase 2
A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI